Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Author:

Gershenwald Jeffrey E.1ORCID,Scolyer Richard A.23,Hess Kenneth R.4,Sondak Vernon K.5,Long Georgina V.6,Ross Merrick I.7,Lazar Alexander J.8,Faries Mark B.9,Kirkwood John M.10,McArthur Grant A.11,Haydu Lauren E.12,Eggermont Alexander M. M.13,Flaherty Keith T.14,Balch Charles M.15,Thompson John F.16,

Affiliation:

1. Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center; The University of Texas MD Anderson Cancer Center; Houston TX

2. Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor; The University of Sydney; Sydney New South Wales Australia

3. Senior Staff Pathologist, Royal Prince Alfred Hospital; Sydney New South Wales Australia

4. Professor, Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX

5. Chair, Department of Cutaneous Oncology; Moffitt Cancer Center; Tampa FL

6. Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia; The University of Sydney and Royal North Shore Hospital; Sydney New South Wales Australia

7. Professor of Surgery, Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX

8. Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics; The University of Texas MD Anderson Cancer Center; Houston TX

9. Co-Director, Melanoma Program; Head, Surgical Oncology; The Angeles Clinic and Research Institute; Los Angeles CA

10. Professor of Medicine, Dermatology, and Translational Science; The University of Pittsburgh School of Medicine; Pittsburgh PA

11. Executive Director, Victorian Comprehensive Cancer Center; Melbourne Victoria Australia

12. Manager, Clinical Data Management Systems; The University of Texas MD Anderson Cancer Center; Houston TX

13. Director General, Gustave Roussy Cancer Institute; Villejuif France

14. Director, Termeer Center for Targeted Therapy; Massachusetts General Hospital Cancer Center; Boston MA

15. Professor of Surgery, The University of Texas MD Anderson Cancer Center; Houston TX

16. Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia; The University of Sydney and Royal Prince Alfred Hospital; Sydney New South Wales Australia.

Funder

National Institutes of Health Specialized Program of Research Excellence (SPORE) Melanoma

National Institutes of Health

National Cancer Institute

University of Texas MD Anderson Cancer Center

Melanoma Research Alliance

Robert and Lynne Grossman Family Foundation

Michael and Patricia Booker Melanoma Research Endowment

National Health and Medical Research Council

University of Sydney

Publisher

Wiley

Subject

Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3